Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.

NCT06145048 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vergent Bioscience, Inc.